Terry Smith

 Terry Smith
Professor Emeritus of Ophthalmology and Visual Sciences
Professor Emeritus of Internal Medicine, Medical School
Email:
[email protected]
Available to mentor
Terry Smith
Terry Smith
Professor Emeritus/a
  • Recent Publications

  • Manage Your Profile

    • Recent Publications

     See All Publications
    • Journal Article
      Insulin-like Growth Factor Signaling Promotes Corneal Myofibroblast Survival and Sustains Corneal Fibrosis
      Hwang Y, Son KN, Chaudhary M, Lee E, Kim M, You S, Smith TJ, Aakalu VK, Han KY. International Journal of Molecular Sciences, 2026 Aug 1; 27 (16): DOI:10.3390/ijms27167320
      PMID: 42653325
    • Journal Article
      Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study
      Bach E, Breschi A, Wang Y, Carroll MK, Luk W, Han A, Short S, Cimermančič P, Drake KA, Cook LJ, Snyder T, Smith TJ, Yeaman MR, Kim CC. Neurology Neuroimmunology and Neuroinflammation, 2026 Jul 1; 13 (4): DOI:10.1212/NXI.0000000000200611
      PMID: 42335442
    • Journal Article
      Approach to the patient: therapeutic mitigation of lacrimal manifestations in thyroid eye disease
      Reinhardt C, Fotovat N, Siddiqui O, Ong J, Aakalu VK, Smith TJ. Journal of Clinical Endocrinology and Metabolism, 2026 May 1; 111 (5): e1435 - e1445. DOI:10.1210/clinem/dgag045
      PMID: 41649397
    • Journal Article
      Management of Thyroid Eye Disease: A Comparison Between Three Recent Clinical Guidelines
      Lei C, Jin J, Li R, Yip CC, Chong KKL, Smith TJ, Sun J, Zhou H. Ophthalmology and Therapy, 2026 Mar 1; 15 (3): 985 - 999. DOI:10.1007/s40123-026-01326-z
    • Journal Article
      SPHERES: innovative registry addressing the new era of neuromyelitis optica spectrum disorders (NMOSD) therapy
      Bennett JL, Middaugh N, Yeaman MR, Smith TJ, Behne MK, Crabtree M, McLean RR, Pappas DA, Levy M. Multiple Sclerosis and Related Disorders, 2026 Mar 1; 107: DOI:10.1016/j.msard.2025.106940
      PMID: 41447909
    • Journal Article
      Efficacy and Safety of IGF-1 Receptor Inhibitors for Thyroid Eye Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials
      Zhang H, Zhang Z, Lu T, Chew SP, Zhang H, Li Y, Smith TJ, Zhou H. Drugs, 2026 Jan 1; DOI:10.1007/s40265-026-02388-w
    • Journal Article
      Safety profile of teprotumumab-trbw, the first and only FDA-approved treatment for thyroid-associated ophthalmopathy
      Smith TJ. Expert Opinion on Drug Safety, 2026 Jan 1; DOI:10.1080/14740338.2026.2690266
      PMID: 42295149
    • Journal Article
      Thyroid Eye Disease (TED) Monocytes Express a Functional Thyrotropin Receptor and Express Increased IL-6 and IL-8: Possible Mechanistic Implications
      Douglas RS, Ugradar S, Mester T, Parunakian E, Smith TJ. Ophthalmic Plastic and Reconstructive Surgery, 2026 Jan 1; Publish Ahead of Print: DOI:10.1097/IOP.0000000000003158
      PMID: 41687076